2023 Form 5500 filing — Yumanity Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20250324163037NAL0013068641001) for Yumanity Therapeutics, Inc. 401(K) Plan, reported by Yumanity Therapeutics, Inc. under EIN 20-8436652 and plan number 001. It reports 59 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$59.5KReported net assets$59,486
Participants59
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20250324163037NAL0013068641001
Plan sponsor
Yumanity Therapeutics, Inc.
EIN
20-8436652
Plan number
001
Location
Mercer Island, WA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$59.5K total assets
Net assets$59.5KLiabilities$0
Money in vs. money out
Total income / additions$414.3K
Total expenses$6.7M
Benefits paid / distributions$6.7M
Contributions
Employer$2
Participant-$2
Full reported line items
Total assets (EOY)
$59,486
Total liabilities (EOY)
$0
Net assets (EOY)
$59,486
Employer contributions
$2
Participant contributions
-$2
Total income / additions
$414,342
Benefits paid
$6,733,659
Administrative expenses
$3,735
Total expenses
$6,737,394
Net increase / (decrease)
-$6,323,052

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20250324163037NAL0013068641001 cover?
It is the 2023 Form 5500 filing for Yumanity Therapeutics, Inc. 401(K) Plan, reported by Yumanity Therapeutics, Inc. (EIN 20-8436652).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages